PubMed Health⌕ Search

Biomedical subjects

A J Mikulski

Publications and source records attributed to A J Mikulski.

13 recordsLinked to original sources
PubMed1995

Endogenous lipids in matrix-induced bone morphogenesis.

Demineralized matrix was delipidized with chloroform methanol before and after demineralization and implanted in muscle of allogeneic rats. Because lipids are difficult to separate completely from bone collagen, another preparation was gelatinized and delipidized with either chloroform methanol or acetone or both. Bone matrix demineralized without delipidization induced formation of a spherical-shaped deposit of new bone, which was remodeled to form a shell of cortical bone and central pool of normal hematopoietic bone marrow. When the bone was delipidized, only 20% to 25% was resorbed and replaced by new bone; unresorbed matrix failed to recalcify. Gelatinized bone matrix delipidized before implantation was even less well resorbed or replaced by new bone, but 12% to 44% of the matrix residue recalcified. The new deposits of bone were colonized by blood-borne bone marrow-derived stem cells and developed central pools of normal hematopoietic bone marrow. Recalcified residual matrix did not develop bone marrow. Additional investigations are required to determine whether the host bed adipocytes provide the phospholipids for recalcification of bone matrix. There was no preliminary recalcification in matrix-induced bone development, even though the 2 processes may occur simultaneously under specified experimental and pathologic conditions. Additional investigations are in progress to determine whether certain acetone soluble lipids may form the endogenous delivery system for bone morphogenetic protein and induced bone development.

Adipocytes↗
PubMed1980

Large scale purification of human fibroblast interferon.

Human fibroblast interferon was partially purified, about 4,000-fold, on a chromatographic tandem of columns: concanavalin A-agarose leads to phenyl-agarose, to a specific activity of ca 4 x 10(7). The overall recovery of interferon activity was ca 60%.

Chromatography, Agarose↗
PubMed1979

Copper chelate affinity chromatography of human fibroblast and leucocyte interferons.

Human fibroblast and human leucocyte interferons display a strong affinity for the copper chelate of bis-carboxymethyl amino agarose, binding tenaciously over a wide pH range (7.4 to 4.0). Their binding is apparently irreversible on a sorbent saturated with copper (24.8 mumol of Cu2+/ml of column bed). However, both interferons can be partially recovered from sorbents of lower copper content, prepared by leaching the columns with sodium citrate at pH 9.0. The recovery of fibroblast interferon from a leached sorbent (5.8 mumol of Cu2+/ml of column bed) is about 30% and that of leucocyte interferon about 60%. Moreover, the strength of binding of leucocyte interferon can be modulated by leaching copper chelate-agarose with citrate of varying concentration.

Cells, Cultured↗
PubMed1978

Stabilization of human fibroblast interferon purified on concanavalin A-agarose.

Human fibroblast interferon, obtained by chromatography on concanavalin A-agarose, was stable for at least a month in 30--50 per cent ethylene glycol at 4 degrees, --20 degrees, and --70 degrees C. The succinct point of the present finding is that human fibroblast interferon may be stabilized by ethylene glycol alone without the addition of bovine serum albumin and 'back-contamination' of the interferon preparation.

Chromatography, Affinity↗
PubMed1977

Collagenase-released non-collagenous proteins of cortical bone matrix.

Two distinct groups of non-collagenous components were isolated from rat cortical bone gelatin which had previously been digested with purified bacterial collagenase. One component was disulfide-bonded, strongly acidic, trypsin-labile glycoprotein aggregate with a molecular mass of more than 100,000 daltons. When reduced with beta-mercaptoethanol this protein disaggregated into subunits with a molecular mass of about 60,000 daltons. The other components consisted of a group of polypeptides with a molecular mass of about 5,000 daltons. The latter group was present in collagenase digests prepared from normal bone gelatin but was hardly detectable or absent in digests of gelatin prepared from either autolyzed, trypsinized or lathyritic bone, or from the residue of neutral salt extracted rat tail tendon.

Amino Acids↗
PubMed1977

A bone matrix calcification-initiator noncollagenous protein.

When completely demineralized, the densely packed structure of bone matrix does not recalcify, neither in physiologic solutions in vitro nor in implants in vivo. Even when inorganic and organic calcification inhibitors (which normally are stored in bone matrix) are removed first by autolytic digestion in neutral buffers at 37C and then by sequential chemical extraction, implants of the EDTA insoluble residue will not recalcify after as long as 4 wk in a muscle pouch. However, if first demineralized in cold dilute HCl, second, extracted and autodigested in buffers solution at 37C, and then further extracted in EDTA and other solutions at 2C, a calcification initiator protein (Cp) is unmasked, and the residue will invariable recalcify. CIP, isolated by gel filtration and column chromatography, is a disulfide-bonded glycoprotein aggregate composed of subunites of a moleclar mass of 55,000. CIP is composed of a large proportion of acidic amino acids and has a calcium binding capacity of about 1.8 times greater than albumin. The affinity constant CaCIP, calculated by ultrafiltration of physiologic solutions of Ca2+, is log K, 2.9. Observations on implants of residues that containe a) CIP but not a bone morphogenetic property (BMP), B) BMP accompanied by CIP activity, or c) neither BMP nor CIP activity suggested that BMP covers CIP and that the two are attached to bone collagen in tandem. Whether CIP plays a part in calcification of the normal skeleton requires further investigation.

Amino Acids↗
PubMed1975

Polynucleotides containing 5-mercapto-substituted pyrimidines: inhibition of viral DNA polymerases and the biological implication.

Partially thiolated polycytidylic acids MPC I-III, containing 1.7%, 3.5% and 8.6% 5-mercaptocytidylate units, respectively) inhibited the DNA polymerase of Friend leukemia virus (FLV) in the endogenic reaction as well as in the presence of poly(A)-(dT)14 or poly[d(a-T)] templates; the inhibitory activities were directly related to the percent of thiolation. Various partially thiolated RNA and DNA isolates from Ehrlich ascites cells (containing one 5-mercaptopyrimidine nucleotide/50-100 nucleotide units) also inhibited the DNA polymerases of FLV in the endogenic reaction, and also in the presence of the synthetic templates. The thiolated DNA was the most active, but the thiolated tRNA also showed substantial inhibitory effects, while the thiolated ribosomal RNA was less effective. In a bacterial DNA polymerase (E. coli-K12, using denatured DNA as template), MPC I-III showed no activity. By contrast, MPC III and several partially thiolated nucleic acid isolates significantly inhibited a regenerating rat liver DNA polymerase (I) system; among those tested, the thiolated DNA from Ehrlich ascites cells showed the highest activity. Kinetic analysis of the inhibitory action of this thiolated DNA in the rat liver enzyme system, using as template the corresponding unmodified DNA, demonstrated that the thiolated DNA acts as a competitive inhibitor of the template, with a Ki/Km ratio of 0.5.

Animals↗
PubMed1975

An antigenic antimorphogenetic bone hydrophobic glycopeptide (AHG).

A hydrophobic glycopeptide, isolated from fresh marrow-free cortical bone of the rat, extinguished the bone morphogenetic response of insoluble bone matrix gelatin which otherwise invariably produces new bone from migrating mesenchymal cells after implantation in muscle of the rat. Incubation of the 10 to 100 mug of the glycopeptide per milligram of bone gelatin in phosphate or Tris-HCl buffer, pH = 7.4, for 24 hours recombines the hydrophobic polypeptide and gelatin. Incubated with doses of 50 to 100 mug, implants of gelatin in Sprague-Dawley recipients are rapidly resorbed by a lymphocyte-plasma cell-macrophage infiltrate without developing any new bone. With 10 to 20 mug, infiltrate appears and bone develops inversely in proportion to the dose. Bone develops at all dose levels only when bone matrix gelatin and glycopeptide were prepared from an inbred strain of Lewis rats and recipients were of the same strain, and thereby suggests that only allogeneic AHG, produces an antigenic antimorphogenetic resonse. The glycopeptide was isolated from bone together with lipids and other hydrophobic proteins or polypeptides by chloroform-methanol (1:1) extraction and further purified by chromatography on ion-exchange columns and molecular sieves. The molecular weight established by Sephadex G-100 filtration and by calibrated dialysis is about 5000 daltons. Analysis of the biologically active fraction shows 75% of proteinaceous material and close to 25% carbohydrate with trace amounts of hexosamines and sialic acid. Amino acid analysis shows high levels of alanine, valine and leucine in comparison to other chloroform-methanol extractable but immunogenically relatively-inactive fractions.

Amino Acids↗